Calendar and upcoming reports
April 30, 2025
Interim Report Q1 2025 (7:00am CEST)
May 6, 2025
Annual General Meeting
Investors
Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment
April 30, 2025
Interim Report Q1 2025 (7:00am CEST)
May 6, 2025
Annual General Meeting
Share
Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden
Phone: +46 8 679 72 10
E-mail: [email protected]
